Table 3.
Proportion of inappropriate medications and proportion of patients receiving inappropriate medications according to MAI criteria
| MAI CRITERIA |
MEDICATIONS, %
|
PATIENTS, %
|
||
|---|---|---|---|---|
| BASELINE (N = 764) | END POINT (N = 774) | BASELINE (N = 112) | END POINT (N = 114) | |
| Indication | 3.0 | 0.6* | 17.9 | 3.5* |
| Effectiveness | 1.0 | 0.4* | 6.3 | 2.6 |
| Dosage | 5.5 | 1.0* | 32.1 | 6.1* |
| Correct directions | 3.8 | 1.7* | 21.4 | 9.6† |
| Practical directions | 7.1 | 3.5* | 33.0 | 20.2† |
| Drug-drug interactions | 6.7 | 0.8* | 24.1 | 1.8* |
| Drug-disease interactions | 3.9 | 0.8* | 23.2 | 5.3* |
| Duplication | 2.4 | 0.9* | 10.7 | 5.3 |
| *Statistically significant change at P < .001. | 7.3 | 2.5* | 33.9 | 13.2* |
| †Statistically significant change at P < .05. | 27.2 | 8.9* | 77.7 | 38.6* |
MAI – medication appropriateness index.
*
Statistically significant change at P < .001.
†
Statistically significant change at P < .05.